GHRP-6 is a secretagogue peptide used to increase the amount of natural secretion growth hormone in the body of animal test subjects. It is a hexipeptide; that is, it contains special chain made up of six amino acids.
GHRP-6 has been determined through scientific research to cause an increase in stimulation of the pituitary gland in animal test subjects. This tiny gland located at the brain’s base is chiefly responsible for regulating several important bodily processes including:
- Water regulation
- Thyroid gland functionality
- Pain relief
- Blood pressure
- Temperature regulation
GHRP-6’s presence inhibits the gland’s capability to block hormone productions in an animal test subject, which in turn results in an enhanced ability to produce hormones related to an animal test subject’s growth. Additionally, the peptide impacts an animal test subject’s central nervous system, as it assists in the activation of intracellular signaling pathways used by hormones as it elevates the process of cell survival. This correlation between the central nervous system and the peptide has led researchers to theorize that it could have a significant effect of guarding cell loss and function during hypoxic-ischemic brain injuries such as a stroke.
A second component to GHRP-6’s functionality is how it works with ghrelin; the amino acid primarily produced by the stomach as a means to stimulate hunger. The peptide increases the production of ghrelin, which enables animal test subjects to feel hungry longer. This then elevates the need for a higher intake of food, and this intake provides more fuel which can then be converted into the hormones secreted by the pituitary gland in animal test subjects.
What’s more, GHRP-6 leads to an elevated secretion of IGF-1. According to scientific research, this natural secretion is determined to be the primary anabolic mechanism for the hormone that promotes growth in animal test subjects. These studies show that GHRP-6 promotes a higher release of IGF-1 through the animal test subjects’ central nervous system.
GHRP-6’s Theoretical Benefits
Currently, GHRP-6 is being scientifically studied on animal test subjects. These studies have led to the theory that the peptide could have several theoretical benefits, including:
- Muscle growth increase – GHRP-6’s chief mechanism allows it to promote the increase in secretion of the hormone that causes growth in animal test subjects, which in turn aid and promote the further development of muscle mass. These hormones can also speed up the process of muscle and tissue repair.
- Body fat decrease – Although GHRP-6 elevates the production of ghrelin and increases hunger, the peptide’s capability to allow the liver to secrete an elevated level of IGF-1 enables energy to burn faster in animal test subjects. This results in the subjects’ bodies being able to break down fat tissue more efficiently. This process has also led to a theory that an animal test subject could experience weight gain if the increased food is not converted to energy.
- Bone tissue growth increase – GHRP-6’s promotion in hormone secretion also aids in creating an increased bone density amongst animal test subjects.
- Increased Immune System Efficiency – GHRP-6’s ability to stimulate the pituitary gland allows for animal test subjects to heal from injury and illness more efficiently. This process ties into the pituitary gland’s ability to promote pain and injury recovery through the body.
- Connective tissue and joint strengthening – Because GHRP-6’s mechanics promote growth hormone production in animal test subjects, studies have theorized that joints and connective tissue could be repaired quicker.
GHRP-6’s Theoretical Side Effects
Even though scientific research through animal test subjects have determined several theoretical benefits linked to GHRP’6, several case studies have also determined that the peptide does theoretically have some negative side effects. Among these negative theoretical side effects are:
- Increase in hunger
- Soreness of bones
- Tingling or numbness on the skin
- Reduction of touch sensitivity
In addition, some scientific research conducted on animal test subjects have led to the theory that GHRP-6 could cause hypoglycemia. However, there have not be conclusive enough studies or anecdotal evidence on record that hold up these particular theories.
For Case Study Only
As of right now, GHRP-6 is still locked in the scientific study phase. All findings, reports, and theories in relation to the peptide’s operation, mechanics, theorized benefits, or speculated side effects have been culled from scientific research conducted on animal test subjects. Any surveillance related to GHRP-6 and its mechanics and processes should be contained to a strictly controlled and regulated environment, such as a laboratory or a research facility.